Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

Negative cooperativity in NAD(P)H quinone oxidoreductase 1 (NQO1).

Megarity CF, Abdel-Aal Bettley H, Caraher MC, Scott KA, Whitehead RA, Jowitt TA, Gutierrez A, Bryce RA, Nolan KA, Stratford IJ, Timson DJ.

Chembiochem. 2019 Jun 5. doi: 10.1002/cbic.201900313. [Epub ahead of print]

PMID:
31165578
2.

Neratinib after trastuzumab-based adjuvant therapy in patients from Asia with early stage HER2-positive breast cancer.

Iwata H, Masuda N, Kim SB, Inoue K, Rai Y, Fujita T, Chiu J, Ohtani S, Takahashi M, Miyaki T, Lu YS, Xu B, Yap YS, Bustam A, Yao B, Zhang B, Bryce R, Chan A.

Future Oncol. 2019 May 29. doi: 10.2217/fon-2019-0143. [Epub ahead of print]

PMID:
31140297
3.

Altering standard admission order sets to promote clinical laboratory stewardship: a cohort quality improvement study.

Leis B, Frost A, Bryce R, Lyon AW, Coverett K.

BMJ Qual Saf. 2019 May 9. pii: bmjqs-2018-008995. doi: 10.1136/bmjqs-2018-008995. [Epub ahead of print]

PMID:
31073090
4.

Erratum to: Advanced Glycation End Products: Receptors for Advanced Glycation End Products Axis in Coronary Stent Restenosis: A Prospective Study.

Pearce C, Islam N, Bryce R, McNair ED.

Int J Angiol. 2018 Dec;27(4):e1. doi: 10.1055/s-0038-1676383. Epub 2019 Jan 8.

5.

Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancers.

Hyman DM, Piha-Paul SA, Won H, Rodon J, Saura C, Shapiro GI, Juric D, Quinn DI, Moreno V, Doger B, Mayer IA, Boni V, Calvo E, Loi S, Lockhart AC, Erinjeri JP, Scaltriti M, Ulaner GA, Patel J, Tang J, Beer H, Selcuklu SD, Hanrahan AJ, Bouvier N, Melcer M, Murali R, Schram AM, Smyth LM, Jhaveri K, Li BT, Drilon A, Harding JJ, Iyer G, Taylor BS, Berger MF, Cutler RE Jr, Xu F, Butturini A, Eli LD, Mann G, Farrell C, Lalani AS, Bryce RP, Arteaga CL, Meric-Bernstam F, Baselga J, Solit DB.

Nature. 2019 Feb;566(7745):E11-E12. doi: 10.1038/s41586-019-0974-0.

PMID:
30755741
6.

Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial.

Delaloge S, Cella D, Ye Y, Buyse M, Chan A, Barrios CH, Holmes FA, Mansi J, Iwata H, Ejlertsen B, Moy B, Chia SKL, Gnant M, Smichkoska S, Ciceniene A, Martinez N, Filipović S, Ben-Baruch NE, Joy AA, Langkjer ST, Senecal F, de Boer RH, Moran S, Yao B, Bryce R, Auerbach A, Fallowfield L, Martin M.

Ann Oncol. 2019 Apr 1;30(4):567-574. doi: 10.1093/annonc/mdz016.

PMID:
30689703
7.

The characterization, management, and future considerations for ErbB-family TKI-associated diarrhea.

Rugo HS, Di Palma JA, Tripathy D, Bryce R, Moran S, Olek E, Bosserman L.

Breast Cancer Res Treat. 2019 May;175(1):5-15. doi: 10.1007/s10549-018-05102-x. Epub 2019 Jan 22. Review.

8.

Neratinib in Combination With Trastuzumab for the Treatment of Patients With Advanced HER2-positive Breast Cancer: A Phase I/II Study.

Blackwell KL, Zaman K, Qin S, Tkaczuk KHR, Campone M, Hunt D, Bryce R, Goldstein LJ; 202 Study Group.

Clin Breast Cancer. 2019 Apr;19(2):97-104.e4. doi: 10.1016/j.clbc.2018.12.011. Epub 2018 Dec 20.

PMID:
30655172
9.

Advanced Glycation End Products:Receptors for Advanced Glycation End Products Axis in Coronary Stent Restenosis: A Prospective Study.

Pearce C, Islam N, Bryce R, McNair ED.

Int J Angiol. 2018 Dec;27(4):213-222. doi: 10.1055/s-0038-1673660. Epub 2018 Oct 29. Erratum in: Int J Angiol. 2018 Dec;27(4):e1.

PMID:
30410293
10.

Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2).

Cocco E, Javier Carmona F, Razavi P, Won HH, Cai Y, Rossi V, Chan C, Cownie J, Soong J, Toska E, Shifman SG, Sarotto I, Savas P, Wick MJ, Papadopoulos KP, Moriarty A, Cutler RE Jr, Avogadri-Connors F, Lalani AS, Bryce RP, Chandarlapaty S, Hyman DM, Solit DB, Boni V, Loi S, Baselga J, Berger MF, Montemurro F, Scaltriti M.

Sci Signal. 2018 Oct 9;11(551). pii: eaat9773. doi: 10.1126/scisignal.aat9773.

PMID:
30301790
11.

Evaluation of emergency department ultrasound machines for the presence of occult blood.

Poonja Z, Uppal J, Netherton SJ, Bryce R, Lyon AW, Cload B.

CJEM. 2019 May;21(3):395-398. doi: 10.1017/cem.2018.447. Epub 2018 Oct 2.

PMID:
30277177
12.

Extended Adjuvant Therapy with Neratinib Plus Fulvestrant Blocks ER/HER2 Crosstalk and Maintains Complete Responses of ER+/HER2+ Breast Cancers: Implications to the ExteNET Trial.

Sudhan DR, Schwarz LJ, Guerrero-Zotano A, Formisano L, Nixon MJ, Croessmann S, González Ericsson PI, Sanders M, Balko JM, Avogadri-Connors F, Cutler RE, Lalani AS, Bryce R, Auerbach A, Arteaga CL.

Clin Cancer Res. 2019 Jan 15;25(2):771-783. doi: 10.1158/1078-0432.CCR-18-1131. Epub 2018 Oct 1.

PMID:
30274983
13.

Sleep and Exercise in Emergency Medicine Residents: An Observational Pilot Study Exploring the Utility of Wearable Activity Monitors for Monitoring Wellness.

Poonja Z, O'Brien P, Cross E, Bryce R, Dance E, Jaggi P, Krentz J, Thoma B.

Cureus. 2018 Jul 12;10(7):e2973. doi: 10.7759/cureus.2973.

14.

Annually and monthly resolved solar irradiance and atmospheric temperature data across the Hawaiian archipelago from 1998 to 2015 with interannual summary statistics.

Bryce R, Losada Carreño I, Kumler A, Hodge BM, Roberts B, Brancucci Martinez-Anido C.

Data Brief. 2018 May 23;19:896-920. doi: 10.1016/j.dib.2018.05.099. eCollection 2018 Aug.

15.

Severity of allergic rhinitis assessed by using urine metabolomic profiling: Proof of concept.

Adamko DJ, Khamis MM, Steacy LM, Regush S, Bryce R, Ellis AK.

J Allergy Clin Immunol. 2018 Aug;142(2):687-689.e6. doi: 10.1016/j.jaci.2018.02.051. Epub 2018 Apr 17. No abstract available.

PMID:
29678748
16.

Evaluation of analogues of furan-amidines as inhibitors of NQO2.

Alnabulsi S, Hussein B, Santina E, Alsalahat I, Kadirvel M, Magwaza RN, Bryce RA, Schwalbe CH, Baldwin AG, Russo I, Stratford IJ, Freeman S.

Bioorg Med Chem Lett. 2018 May 1;28(8):1292-1297. doi: 10.1016/j.bmcl.2018.03.025. Epub 2018 Mar 12.

PMID:
29567345
17.

Randomized Clinical Trial Evaluating Complications and Complication-Related Removal of Arm-Situated Power-Injectable and Non-Power-Injectable Totally Implanted Venous Access Devices among Cancer Patients.

Burbridge B, Plewes C, Stoneham G, Szkup P, Otani R, Babyn P, Bryce R.

J Vasc Interv Radiol. 2018 May;29(5):648-656.e3. doi: 10.1016/j.jvir.2017.11.028. Epub 2018 Mar 2.

PMID:
29499999
18.

Incidence and Economic Impact of Incidental Findings on 18F-FDG PET/CT Imaging.

Adams SJ, Rakheja R, Bryce R, Babyn PS.

Can Assoc Radiol J. 2018 Feb;69(1):63-70. doi: 10.1016/j.carj.2017.08.001.

PMID:
29458956
19.

HER kinase inhibition in patients with HER2- and HER3-mutant cancers.

Hyman DM, Piha-Paul SA, Won H, Rodon J, Saura C, Shapiro GI, Juric D, Quinn DI, Moreno V, Doger B, Mayer IA, Boni V, Calvo E, Loi S, Lockhart AC, Erinjeri JP, Scaltriti M, Ulaner GA, Patel J, Tang J, Beer H, Selcuklu SD, Hanrahan AJ, Bouvier N, Melcer M, Murali R, Schram AM, Smyth LM, Jhaveri K, Li BT, Drilon A, Harding JJ, Iyer G, Taylor BS, Berger MF, Cutler RE Jr, Xu F, Butturini A, Eli LD, Mann G, Farrell C, Lalani AS, Bryce RP, Arteaga CL, Meric-Bernstam F, Baselga J, Solit DB.

Nature. 2018 Feb 8;554(7691):189-194. doi: 10.1038/nature25475. Epub 2018 Jan 31. Erratum in: Nature. 2019 Feb;566(7745):E11-E12.

20.

Identification of Rare Lewis Oligosaccharide Conformers in Aqueous Solution Using Enhanced Sampling Molecular Dynamics.

Alibay I, Burusco KK, Bruce NJ, Bryce RA.

J Phys Chem B. 2018 Mar 8;122(9):2462-2474. doi: 10.1021/acs.jpcb.7b09841. Epub 2018 Feb 28.

PMID:
29419301
21.

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.

Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A; ExteNET Study Group.

Lancet Oncol. 2017 Dec;18(12):1688-1700. doi: 10.1016/S1470-2045(17)30717-9. Epub 2017 Nov 13.

PMID:
29146401
22.

Non-enzymatic recombination of RNA: Ligation in loops.

Staroseletz Y, Nechaev S, Bichenkova E, Bryce RA, Watson C, Vlassov V, Zenkova M.

Biochim Biophys Acta Gen Subj. 2018 Mar;1862(3):705-725. doi: 10.1016/j.bbagen.2017.10.019. Epub 2017 Oct 31.

PMID:
29097301
23.

Comparative Molecular Dynamics Simulation of Aggregating and Non-Aggregating Inhibitor Solutions: Understanding the Molecular Basis of Promiscuity.

Ghattas MA, Bryce RA, Al Rawashdah S, Atatreh N, Zalloum WA.

ChemMedChem. 2018 Mar 20;13(6):500-506. doi: 10.1002/cmdc.201700654. Epub 2017 Nov 24.

PMID:
29058775
24.

Boron-Based Inhibitors of the NLRP3 Inflammasome.

Baldwin AG, Rivers-Auty J, Daniels MJD, White CS, Schwalbe CH, Schilling T, Hammadi H, Jaiyong P, Spencer NG, England H, Luheshi NM, Kadirvel M, Lawrence CB, Rothwell NJ, Harte MK, Bryce RA, Allan SM, Eder C, Freeman S, Brough D.

Cell Chem Biol. 2017 Nov 16;24(11):1321-1335.e5. doi: 10.1016/j.chembiol.2017.08.011. Epub 2017 Sep 21.

25.

Trajectories of pain severity in juvenile idiopathic arthritis: results from the Research in Arthritis in Canadian Children Emphasizing Outcomes cohort.

Shiff NJ, Tupper S, Oen K, Guzman J, Lim H, Lee CH, Bryce R, Huber AM, Boire G, Dancey P, Feldman B, Laxer R, Miettunen P, Schmeling H, Watanabe Duffy K, Levy DM, Turvey S, Bolaria R, Bruns A, Cabral DA, Campillo S, Chédeville G, Feldman DE, Haddad E, Houghton K, Johnson N, Jurencak R, Lang B, Larche M, Morishita K, Ramsey S, Roth J, Schneider R, Scuccimarri R, Spiegel L, Stringer E, Tse SM, Yeung R, Duffy CM, Tucker LB.

Pain. 2018 Jan;159(1):57-66. doi: 10.1097/j.pain.0000000000001064.

PMID:
28937578
26.

Standard admission order sets promote ordering of unnecessary investigations: a quasi-randomised evaluation in a simulated setting.

Leis B, Frost A, Bryce R, Coverett K.

BMJ Qual Saf. 2017 Nov;26(11):938-940. doi: 10.1136/bmjqs-2017-006898. Epub 2017 Sep 14. No abstract available.

PMID:
28912197
27.

Participation in a farmers' market fruit and vegetable prescription program at a federally qualified health center improves hemoglobin A1C in low income uncontrolled diabetics.

Bryce R, Guajardo C, Ilarraza D, Milgrom N, Pike D, Savoie K, Valbuena F, Miller-Matero LR.

Prev Med Rep. 2017 Jun 27;7:176-179. doi: 10.1016/j.pmedr.2017.06.006. eCollection 2017 Sep.

28.

Point-of-Care Ultrasound for Jugular Venous Pressure Assessment: Live and Online Learning Compared.

Socransky S, Lang E, Bryce R, Betz M.

Cureus. 2017 Jun 8;9(6):e1324. doi: 10.7759/cureus.1324.

29.

Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer.

Ma CX, Bose R, Gao F, Freedman RA, Telli ML, Kimmick G, Winer E, Naughton M, Goetz MP, Russell C, Tripathy D, Cobleigh M, Forero A, Pluard TJ, Anders C, Niravath PA, Thomas S, Anderson J, Bumb C, Banks KC, Lanman RB, Bryce R, Lalani AS, Pfeifer J, Hayes DF, Pegram M, Blackwell K, Bedard PL, Al-Kateb H, Ellis MJC.

Clin Cancer Res. 2017 Oct 1;23(19):5687-5695. doi: 10.1158/1078-0432.CCR-17-0900. Epub 2017 Jul 5.

30.
31.

A determination of emergency department pre-triage times in patients not arriving by ambulance compared to widely used guideline recommendations - CORRIGENDUM.

Betz M, Stempien J, Trivedi S, Bryce R.

CJEM. 2017 Mar;19(2):166. doi: 10.1017/cem.2017.18. Epub 2017 Feb 27. No abstract available.

PMID:
28238290
32.

Initial Experience Using a Telerobotic Ultrasound System for Adult Abdominal Sonography.

Adams SJ, Burbridge BE, Badea A, Langford L, Vergara V, Bryce R, Bustamante L, Mendez IM, Babyn PS.

Can Assoc Radiol J. 2017 Aug;68(3):308-314. doi: 10.1016/j.carj.2016.08.002. Epub 2017 Jan 31.

PMID:
28159435
33.

miRNases: Novel peptide-oligonucleotide bioconjugates that silence miR-21 in lymphosarcoma cells.

Patutina OA, Bichenkova EV, Miroshnichenko SK, Mironova NL, Trivoluzzi LT, Burusco KK, Bryce RA, Vlassov VV, Zenkova MA.

Biomaterials. 2017 Apr;122:163-178. doi: 10.1016/j.biomaterials.2017.01.018. Epub 2017 Jan 13.

PMID:
28126663
34.
35.

Conformational study of tylosin A in water and full assignments of 1 H and 13 C spectra of tylosin A in D2 O and tylosin B in CDCl3.

Arsic B, Aguilar JA, Bryce RA, Barber J.

Magn Reson Chem. 2017 Apr;55(4):367-373. doi: 10.1002/mrc.4537. Epub 2016 Oct 27. No abstract available.

PMID:
27711991
36.

Knowing the Enemy: Health Care Provider Knowledge of Computed Tomography Radiation Dose and Associated Risks.

Irving B, Leswick DA, Fladeland D, Lim HJ, Bryce R.

J Med Imaging Radiat Sci. 2016 Sep;47(3):243-250. doi: 10.1016/j.jmir.2016.05.003. Epub 2016 Jun 22.

PMID:
31047289
37.

Satisfaction and Quality of Life Related to Chemotherapy With an Arm Port: A Pilot Study.

Burbridge B, Chan IY, Bryce R, Lim HJ, Stoneham G, Haggag H, Roh C.

Can Assoc Radiol J. 2016 Aug;67(3):290-7. doi: 10.1016/j.carj.2015.11.007. Epub 2016 May 18.

PMID:
27209217
38.

Impact of Management on Avian Communities in the Scottish Highlands.

Newey S, Mustin K, Bryce R, Fielding D, Redpath S, Bunnefeld N, Daniel B, Irvine RJ.

PLoS One. 2016 May 19;11(5):e0155473. doi: 10.1371/journal.pone.0155473. eCollection 2016.

39.

Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial.

Awada A, Colomer R, Inoue K, Bondarenko I, Badwe RA, Demetriou G, Lee SC, Mehta AO, Kim SB, Bachelot T, Goswami C, Deo S, Bose R, Wong A, Xu F, Yao B, Bryce R, Carey LA.

JAMA Oncol. 2016 Dec 1;2(12):1557-1564. doi: 10.1001/jamaoncol.2016.0237.

PMID:
27078022
40.

Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Chan A, Delaloge S, Holmes FA, Moy B, Iwata H, Harvey VJ, Robert NJ, Silovski T, Gokmen E, von Minckwitz G, Ejlertsen B, Chia SK, Mansi J, Barrios CH, Gnant M, Buyse M, Gore I, Smith J 2nd, Harker G, Masuda N, Petrakova K, Zotano AG, Iannotti N, Rodriguez G, Tassone P, Wong A, Bryce R, Ye Y, Yao B, Martin M; ExteNET Study Group.

Lancet Oncol. 2016 Mar;17(3):367-77. doi: 10.1016/S1470-2045(15)00551-3. Epub 2016 Feb 10.

PMID:
26874901
41.

Non-symmetrical furan-amidines as novel leads for the treatment of cancer and malaria.

Alnabulsi S, Santina E, Russo I, Hussein B, Kadirvel M, Chadwick A, Bichenkova EV, Bryce RA, Nolan K, Demonacos C, Stratford IJ, Freeman S.

Eur J Med Chem. 2016 Mar 23;111:33-45. doi: 10.1016/j.ejmech.2016.01.022. Epub 2016 Jan 21.

PMID:
26854376
42.

High Precision Determination of the β Decay Q(EC) Value of (11)C and Implications on the Tests of the Standard Model.

Gulyuz K, Bollen G, Brodeur M, Bryce RA, Cooper K, Eibach M, Izzo C, Kwan E, Manukyan K, Morrissey DJ, Naviliat-Cuncic O, Redshaw M, Ringle R, Sandler R, Schwarz S, Sumithrarachchi CS, Valverde AA, Villari AC.

Phys Rev Lett. 2016 Jan 8;116(1):012501. doi: 10.1103/PhysRevLett.116.012501. Epub 2016 Jan 6.

PMID:
26799013
43.

Free Energy Calculations using a Swarm-Enhanced Sampling Molecular Dynamics Approach.

Burusco KK, Bruce NJ, Alibay I, Bryce RA.

Chemphyschem. 2015 Oct 26;16(15):3233-41. doi: 10.1002/cphc.201500524. Epub 2015 Sep 29.

44.

Metabolic fate of 3α,5-cycloandrostanes in the endogenous lactonization pathway of Aspergillus tamarii KITA.

Hunter AC, Patel S, Dedi C, Dodd HT, Bryce RA.

Phytochemistry. 2015 Nov;119:19-25. doi: 10.1016/j.phytochem.2015.09.003. Epub 2015 Sep 11.

PMID:
26372080
45.

Analysis of Enoyl-Acyl Carrier Protein Reductase Structure and Interactions Yields an Efficient Virtual Screening Approach and Suggests a Potential Allosteric Site.

Ghattas MA, Mansour RA, Atatreh N, Bryce RA.

Chem Biol Drug Des. 2016 Jan;87(1):131-42. doi: 10.1111/cbdd.12635. Epub 2015 Sep 16.

PMID:
26259619
46.

First Direct Determination of the Superallowed β-Decay QEC Value for (14)O.

Valverde AA, Bollen G, Brodeur M, Bryce RA, Cooper K, Eibach M, Gulyuz K, Izzo C, Morrissey DJ, Redshaw M, Ringle R, Sandler R, Schwarz S, Sumithrarachchi CS, Villari AC.

Phys Rev Lett. 2015 Jun 12;114(23):232502. Epub 2015 Jun 12.

PMID:
26196795
47.

Frailty and the prediction of dependence and mortality in low- and middle-income countries: a 10/66 population-based cohort study.

At J, Bryce R, Prina M, Acosta D, Ferri CP, Guerra M, Huang Y, Rodriguez JJ, Salas A, Sosa AL, Williams JD, Dewey ME, Acosta I, Liu Z, Beard J, Prince M.

BMC Med. 2015 Jun 10;13:138. doi: 10.1186/s12916-015-0378-4.

48.

Molecular Dynamics of Cellulose Amphiphilicity at the Graphene-Water Interface.

Alqus R, Eichhorn SJ, Bryce RA.

Biomacromolecules. 2015 Jun 8;16(6):1771-83. doi: 10.1021/acs.biomac.5b00307. Epub 2015 May 27.

PMID:
26015270
49.

E-cigarettes and pregnancy. Is a closer look appropriate?

Bryce R, Robson SJ.

Aust N Z J Obstet Gynaecol. 2015 Jun;55(3):218-21. doi: 10.1111/ajo.12318. Epub 2015 May 20. No abstract available.

PMID:
25996161
50.

Does intravenous lidocaine infusion during video-assisted thoracoscopic surgery reduce postoperative analgesia? A randomized controlled study.

Slovack M, Taylor B, Bryce R, Ong D.

Can J Anaesth. 2015 Jun;62(6):676-7. doi: 10.1007/s12630-015-0333-z. Epub 2015 Feb 11. No abstract available.

PMID:
25670347

Supplemental Content

Support Center